PROFESSIONAL LINGUISTIC & UPPER STUDIES LIMITED
Company number 02965176 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: B+
Explanation: The patient exhibits robust overall constitution, characterized by a strong net worth and excellent profitability. However, there are acute short-term liquidity symptoms—specifically, current liabilities exceeding current assets—and a noted "allergy" in the form of a qualified audit report. The recent repayment of long-term debt acts as a successful course of treatment, significantly improving the long-term prognosis, but the working capital deficit requires ongoing monitoring.
1. Key Vital Signs
- Net Assets (Financial Bone Density): £4,165,331
- Interpretation: Excellent. The company has a very strong equity base, meaning it owns significantly more than it owes. This provides a sturdy skeletal structure to withstand economic shocks.
- Profitability (Metabolic Rate): £679,121
- Interpretation: Very Healthy. After paying all expenses, the business generated a substantial profit. This is a significant improvement in metabolic efficiency compared to previous years, showing the core business (cultural education) is thriving.
- Current Ratio (Blood Pressure): 0.79x (Current Assets £818,593 / Current Liabilities £1,041,462)
- Interpretation: Hypotension (Low Blood Pressure). Ideally, a business wants current assets to exceed current liabilities (a ratio above 1). A ratio of 0.79 means that if all short-term debts came due tomorrow, the company could not pay them from short-term cash or receivables without liquidating long-term investments.
- Cash Position (Hydration Level): £436,672
- Interpretation: Adequate, but slightly low relative to the size of the business. While trade is generating cash, the reserves are modest considering the upcoming obligations.
- Debt Leverage (Cholesterol Levels): Low
- Interpretation: Healthy. Long-term liabilities were reduced from £1.47M to £0.22M during the year, and the notes reveal this Coutts loan was fully repaid shortly after the year-end. The company is not over-leveraged.
2. Symptoms Analysis
Looking beneath the surface numbers reveals some important physiological shifts during the 2025 fiscal year:
- The Vanishing "Other Debtors": In 2024, "Other Debtors" stood at a swollen £2,667,855. In 2025, it dropped to just £104,025. This massive reduction suggests the company was holding a large sum of cash or pending assets in 2024 (possibly linked to the deferred income from the pandemic era or a drawn-down loan waiting to be deployed), which was subsequently settled or utilized in 2025.
- Working Capital Deficit: The company has negative working capital (£-222,869). While the business is generating strong profits, the timing of cash inflows (debtors) versus cash outflows (creditors) is currently misaligned. The business owes more in the next 12 months than it expects to collect in the next 12 months.
- The Investment Anchor: The company is heavily weighted by £4,526,879 in fixed asset investments (a mix of unlisted and listed shares). While this provides a massive financial cushion, these assets are not easily converted to cash to pay short-term bills. It's like having excellent long-term retirement savings but struggling to pay this month's rent.
- Audit Qualification (Pre-existing Condition): The accounts contain a qualified audit opinion. While the text cuts off, a qualification is a red flag indicating the auditors had a disagreement or limitation regarding the financial statements—often related to asset valuations or evidence of transactions. This requires immediate investigation by stakeholders.
3. Diagnosis
Overall Condition: Fundamentally Strong, but experiencing short-term circulatory strain.
The patient is generating excellent margins and has built up significant long-term wealth (Net Assets of £4.1M). The recent eradication of the Coutts loan is akin to successfully clearing a major blockage—the future cash flow burden is dramatically reduced.
However, the business is currently suffering from a working capital deficit. It is relying on the ongoing, timely generation of trade income to meet its short-term obligations (like deferred income and trade creditors). The qualified audit report is a symptom of an underlying compliance or valuation issue that needs a targeted biopsy to fully understand the risk.
4. Recommendations
To improve financial wellness and build resilience, the following "prescriptions" are recommended:
- Improve Working Capital Management (Blood Transfusion): The business needs to accelerate the collection of trade debtors (£36,710) and carefully manage the timing of paying trade creditors (£543,883). Consider negotiating longer payment terms with suppliers or shorter terms with students/clients to ease the cash flow squeeze.
- Investigate the Audit Qualification (Follow-up Consultation): Management must urgently address the reasons behind the qualified audit opinion. A qualification can be a symptom of a deeper illness in financial controls or asset valuation that could deter future lenders or investors.
- Review Dividend Policy (Dietary Adjustment): The company paid out £297,965 in dividends despite having negative working capital. While profits justify a reward to shareholders, paying out cash when short-term liabilities exceed short-term assets puts unnecessary strain on the business's heart. Dividends should be temporarily restricted until the current ratio exceeds 1.0x.
- Liquidity Stress Test (Cardiovascular Check): With over £4.5M tied up in investments, the company should model a scenario where trade income temporarily drops (e.g., a sudden drop in student enrolments). Ensure that the listed shares portion (£141,227) can be liquidated quickly if an emergency cash injection is needed.